Brought to you by 
NanoBio gets $10mm in first close of $30mm financing
07 Mar 2008
Executive Summary
NanoBio (uses nano-emulsion technology to develop vaccines and topical compounds for infectious diseases) raised $10mm in the first of a three-tranche private financing to Perseus LLC that will help support the company's clinical-stage compounds. NanoBio expects to bring in the remaining $20mm, which is contingent upon the achievement of developmental milestones, over the next two years.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Vaccines
-
Drug Delivery
- Topical Delivery
-
Biotechnology
- Drug Discovery Tools
- Nanotechnology, Chips, etc.
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
NanoBio gets $10mm in first close of $30mm financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice